 is not a safe
alternative to iodinated contrast agents, given the risk
for nephrogenic systemic Ô¨Åbrosis in patients with a GFR
of <30 mL/min/1.73 m2.
There is a linear relationship between the volume of
contrast material administered and the onset and
severity of CIN. For every 100 mL of contrast material
infused during coronary artery interventions, there is a
12% increase in the risk for C